Tivity Health Reports Fourth-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Tivity Health (TVTY) PT Lowered to $40 at Cantor Fitzgerald Following 4Q
February 20, 2019 9:23 AM ESTCantor Fitzgerald analyst Steven Halper lowered the price target on Tivity Health (NASDAQ: TVTY) to $40.00 (from $52.00) while maintaining a Overweight rating following the company's 4Q. Revenue of $153M was in line with consensus. Adjusted EPS of $0.67 was above consensus, driven by tax benefits related to... More
Tivity Health, Inc. (TVTY) Tops Q4 EPS by 15c, Slight Miss on Revenues; Offers FY 19 Revenue Guidance
February 19, 2019 4:09 PM ESTTivity Health, Inc. (NASDAQ: TVTY) reported Q4 EPS of $0.73, $0.15 better than the analyst estimate of $0.58. Revenue for the quarter came in at $153 million versus the consensus estimate of $154.02 million.
Revenues increased by 9.8% to $153.0 million compared to revenues of $139.4 million for the fourth quarter of 2017.Income from continuing operations increased to $28.5 million, compared to $8.6 million for the fourth quarter of 2017. Results for the fourth quarter of 2018 include an effective tax rate of 10.1%, primarily due to positive tax benefits related to the vesting of stock-based compensation awards during the quarter. Adjusted income from continuing... More
